Laboratory Nonhuman Primate Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1904118
리서치사:Lucintel
발행일:2026년 01월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 실험실용 비인간 영장류 시장은 위탁 연구 개발 서비스 기관, 과학 연구 기관, 대학 및 고등 교육 기관 시장에서의 기회로 인해 미래가 유망할 것으로 예측됩니다. 세계 실험실용 비인간 영장류 시장은 2025-2031년 연평균 복합 성장률(CAGR) 9.1%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 생물 의학 연구에서의 사용 증가, 의약품 안전성 시험에 대한 수요 증가, 질병 모델 연구에 대한 관심 확대 등입니다.
Lucintel의 예측에 따르면, 유형별 카테고리에서 Macaca fascicularis는 예측 기간 동안 높은 성장률을 보일 것으로 예측됩니다.
용도별로는 위탁연구개발서비스기관(CRO)이 가장 높은 성장률을 보일 것으로 예측됩니다.
지역별로는 아시아태평양(APAC)이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예측됩니다.
실험용 비인간 영장류 시장의 새로운 트렌드
실험실용 비인간 영장류 시장은 기술 발전, 규제 변화, 연구 수요의 진화에 힘입어 큰 변화를 겪고 있습니다. 과학 연구가 고도화됨에 따라 특수 동물 모델에 대한 수요가 증가하면서 번식, 사육 및 윤리 기준의 혁신이 촉진되고 있습니다. 이러한 발전은 시장 구조를 재구성하고 시장 성장에 영향을 미치며 연구 관행의 새로운 표준을 설정하고 있습니다. 이러한 역동적인 환경에서 경쟁력을 유지하고 규제를 준수하고자 하는 이해관계자들에게 이러한 새로운 트렌드를 이해하는 것은 매우 중요합니다. 아래 주요 동향은 현재 실험실용 비인간 영장류 시장을 형성하고 있는 주요 변화의 흐름을 보여줍니다.
유전자 재조합 비인간 영장류 도입 증가: 인간과 유전적 유사성이 높아 유전자 조작된 비인간 영장류의 개발 및 이용이 증가하고 있습니다. 이러한 추세는 질병 모델링과 약물 시험의 정확도를 높이고, 보다 신뢰할 수 있는 연구 성과로 이어집니다. 또한, CRISPR과 같은 첨단 유전자 편집 기술도 활용되어 정밀한 변형이 가능해졌습니다. 이로 인해 특수 NHP에 대한 수요가 급증하고, 번식 프로그램의 혁신을 촉진하고, 윤리적 고려를 강화하는 등 다양한 영향을 미치고 있습니다. 이러한 추세는 보다 타겟팅된 실용성 높은 조사를 가능하게 함으로써 시장을 크게 확대할 것으로 예측됩니다.
윤리적 기준과 복지에 대한 관심 증가: NHP 이용에 따른 윤리적 우려로 인해 규제 강화와 복지 관행의 개선이 진행되고 있습니다. 기관에서는 동물의 복지를 보장하기 위해 사육 환경 개선, 강화, 케어 프로토콜 개선에 힘쓰고 있습니다. 이러한 변화는 시장 관계자들에게 인도적 연구시설과 투명한 관행에 대한 투자를 촉구하고 있습니다. 복지 기준의 개선은 윤리적 문제를 해결할 뿐만 아니라, 스트레스 관련 변동을 줄여 연구 데이터의 질을 향상시킵니다. 결과적으로 이러한 추세는 보다 지속 가능하고 사회적으로 책임감 있는 시장 환경을 조성하고, 동물 보호 및 규제 준수에 대한 혁신을 촉진할 것입니다.
번식 및 관리의 기술적 진보: 자동 번식 시스템, 건강 모니터링 장치, 첨단 수의학 등의 혁신 기술이 비인간 영장류 관리에 변화를 가져오고 있습니다. 이러한 기술은 번식 효율, 건강 상태 추적, 질병 예방, 비용 절감 및 조사 신뢰도 향상을 실현합니다. 인공지능(AI)과 데이터 분석의 통합으로 예측적 건강관리가 가능해져 더 나은 성과로 이어집니다. 이러한 추세는 운영 효율성을 높이고 대규모 연구 프로젝트를 지원합니다. 기술이 비인간 영장류 진료에 더 많이 통합됨에 따라 동물 관리 및 연구 생산성 향상으로 시장 성장이 촉진될 것으로 보입니다.
신경과학 및 감염병 연구에서의 비인간 영장류에 대한 수요 증가: 신경질환 및 감염병이 증가함에 따라 인간의 상태를 충실하게 재현하는 비인간 영장류 모델에 대한 수요가 증가하고 있습니다. 비인간 영장류는 복잡한 뇌 기능 및 면역 반응 연구에 매우 유용합니다. 이러한 수요는 전문 비인간 영장류 사육 시설과 연구시설에 대한 투자를 촉진하고 있습니다. 그 영향으로는 의약품 개발의 가속화와 질병 메커니즘에 대한 이해의 심화를 들 수 있습니다. 연구의 초점이 이러한 분야로 이동함에 따라 시장은 계속 확대되고 있으며, 과학 및 제약 분야 증가하는 요구에 부응하고 모델 개발 및 연구 방법의 혁신을 촉진하고 있습니다.
규제 변화와 국제 협력: 윤리적 조달, 동물 복지, 조사의 투명성을 보장하기 위한 진화하는 규제가 시장 상황을 형성하고 있습니다. 국제 협력은 또한 다양한 영장류 종과 연구 전문 지식에 대한 접근을 촉진하고 있습니다. 이러한 변화는 표준화와 컴플라이언스를 촉진하지만, 운영 비용 증가를 초래할 수 있습니다. 모범 사례 채택을 장려하고 세계 연구 이니셔티브를 육성하고 있습니다. 규제의 복잡성에 대응하는 것은 여전히 과제이지만, 시장은 신뢰도 향상과 연구 기회 확대의 혜택을 누리고 있습니다. 전반적으로 이러한 발전은 보다 규제가 정비되고 협력적이고 윤리의식이 높은 시장 환경을 촉진하고 있습니다.
요약하면, 이러한 새로운 트렌드는 기술 혁신의 촉진, 윤리적 기준의 강조, 연구 용도 확대를 통해 실험용 비인간 영장류 시장을 종합적으로 재구성하고 있습니다. 이는 성장을 가속하고, 연구의 질을 향상시키며, 책임감 있는 실천을 촉진하고, 궁극적으로 보다 발전적이고 지속 가능한 산업으로 이끌고 있습니다.
실험실용 비인간 영장류 시장의 최근 동향
실험실용 비인간 영장류 시장은 생물 의학 연구의 발전, 동물 모델에 대한 수요 증가, 규제 기준의 진화에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 과학 연구가 고도화됨에 따라 신뢰할 수 있고 윤리적으로 조달된 비인간 영장류에 대한 필요성이 급증하고 있습니다. 기술 혁신, 규제 변화, 윤리적 고려가 시장 상황을 형성하고 있습니다. 이러한 발전은 공급망, 연구 방법, 시장 역학에 영향을 미치고, 궁극적으로 전 세계 의료 및 제약 분야에 영향을 미치고 있습니다. 이 진화하는 시장을 효과적으로 탐색하려는 이해관계자들에게 이러한 주요 트렌드를 이해하는 것은 필수적입니다.
생물의학 연구 수요 증가: 알츠하이머병, HIV/AIDS 등의 질병이 증가함에 따라 연구 모델로서 비인간 영장류에 대한 필요성이 높아져 시장 성장을 가속하고 연구 역량을 확대하고 있습니다.
영장류 번식 기술의 발전: 유전공학 및 개량된 번식 기술 등의 혁신으로 영장류의 품질과 가용성이 향상되어 비용 절감과 공급의 안정성을 향상시키고 있습니다.
규제 및 윤리적 고려사항: 영장류 연구를 둘러싼 규제 강화와 윤리적 논의로 인해 조달 기준과 복지 기준이 더욱 엄격해져 공급망에 영향을 미치고 운영 비용이 증가하고 있습니다.
연구 용도 확대: 비인간 영장류는 현재 신경과학, 전염병, 백신 개발 등 다양한 분야에서 사용되고 있으며, 시장의 범위를 넓히고 부문 간 수요를 증가시키고 있습니다.
코로나19 팬데믹의 영향: 팬데믹은 백신 및 치료제 개발을 위한 영장류 연구 활동을 가속화하여 일시적으로 시장 수요를 증가시켰고, 동시에 공급망의 취약성을 부각시켰습니다.
이러한 추세는 종합적으로 수요 증가, 연구 품질 향상, 규제 적응 촉진 등을 통해 실험용 비인간 영장류 시장을 변화시키고 있습니다. 시장은 더욱 고도화되고 윤리의식이 높아졌으며, 과학적 요구에 대한 대응력이 강화되어 향후 몇 년 동안 성장과 혁신이 지속될 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 시장 개요
배경과 분류
공급망
제3장 시장 동향과 예측 분석
거시경제 동향과 예측
업계 촉진요인과 과제
PESTLE 분석
특허 분석
규제 환경
제4장 세계의 실험실용 비인간 영장류 시장 : 유형별
매력 분석 : 유형별
마카크·파시큐라리스
아카게잘
기타
제5장 세계의 실험실용 비인간 영장류 시장 : 용도별
매력 분석 : 용도별
수탁 연구개발 서비스 기관
과학 연구기관
대학·고등교육 기관
기타
제6장 지역별 분석
제7장 북미 실험실용 비인간 영장류 시장
북미 실험실용 비인간 영장류 시장 : 유형별
북미 실험실용 비인간 영장류 시장 : 용도별
미국 실험실용 비인간 영장류 시장
캐나다 실험실용 비인간 영장류 시장
멕시코 실험실용 비인간 영장류 시장
제8장 유럽 실험실용 비인간 영장류 시장
유럽 실험실용 비인간 영장류 시장 : 유형별
유럽 실험실용 비인간 영장류 시장 : 용도별
독일 실험실용 비인간 영장류 시장
프랑스 실험실용 비인간 영장류 시장
이탈리아 실험실용 비인간 영장류 시장
스페인 실험실용 비인간 영장류 시장
영국 실험실용 비인간 영장류 시장
제9장 아시아태평양 실험실용 비인간 영장류 시장
아시아태평양 실험실용 비인간 영장류 시장 : 유형별
아시아태평양 실험실용 비인간 영장류 시장 : 용도별
중국 실험실용 비인간 영장류 시장
인도 실험실용 비인간 영장류 시장
일본 실험실용 비인간 영장류 시장
한국 실험실용 비인간 영장류 시장
인도네시아 실험실용 비인간 영장류 시장
제10장 기타 지역 실험실용 비인간 영장류 시장
기타 지역 실험실용 비인간 영장류 시장 : 유형별
기타 지역 실험실용 비인간 영장류 시장 : 용도별
중동 실험실용 비인간 영장류 시장
남미 실험실용 비인간 영장류 시장
아프리카 실험실용 비인간 영장류 시장
제11장 경쟁 분석
제품 포트폴리오 분석
업무 통합
Porter의 Five Forces 분석
시장 점유율 분석
제12장 기회와 전략 분석
밸류체인 분석
성장 기회 분석
세계의 실험실용 비인간 영장류 시장의 새로운 동향
전략 분석
제13장 밸류체인 전체 주요 기업 개요
Competitive Analysis Overview
Vanny Bio Research
HZ-Bio
Envigo
JOINN LABORATORIES
WuXi AppTec
Jingang Biotech
Charles River
Pharmaron
Xishan Zhongke
ONPRC
제14장 부록
LSH
영문 목차
영문목차
The future of the global laboratory nonhuman primate market looks promising with opportunities in the contract research & development service organization company, scientific research institution, and college & university markets. The global laboratory nonhuman primate market is expected to grow with a CAGR of 9.1% from 2025 to 2031. The major drivers for this market are the increasing use in biomedical research studies, the rising demand for drug safety testing, and the growing focus on disease modeling research.
Lucintel forecasts that, within the type category, macaca fascicularis is expected to witness higher growth over the forecast period.
Within the application category, contract research & development service organization company is expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Laboratory Nonhuman Primate Market
The laboratory nonhuman primate market is experiencing significant transformation driven by technological advancements, regulatory changes, and evolving research needs. As scientific research becomes more sophisticated, the demand for specialized animal models increases, prompting innovations in breeding, care, and ethical standards. These developments are reshaping the landscape, influencing market growth, and setting new standards for research practices. Understanding these emerging trends is crucial for stakeholders aiming to stay competitive and compliant in this dynamic environment. The following key trends highlight the major shifts currently shaping the Laboratory NHP Market.
Increasing Adoption of Genetically Modified NHPs: The development and use of genetically engineered nonhuman primates are rising due to their closer genetic similarity to humans. This trend enhances the accuracy of disease modeling and drug testing, leading to more reliable research outcomes. It also involves advanced gene-editing technologies like CRISPR, which allow for precise modifications. The impact is a surge in demand for specialized NHPs, driving innovation in breeding programs and raising ethical considerations. This trend is expected to significantly expand the market by enabling more targeted and translatable research.
Growing Focus on Ethical Standards and Welfare: Ethical concerns surrounding the use of NHPs are prompting stricter regulations and improved welfare practices. Institutions are adopting better housing, enrichment, and care protocols to ensure animal well-being. This shift influences market players to invest in humane research facilities and transparent practices. Enhanced welfare standards not only address ethical issues but also improve the quality of research data by reducing stress-related variability. Consequently, this trend fosters a more sustainable and socially responsible market environment, encouraging innovation in animal care and regulatory compliance.
Technological Advancements in Breeding and Care: Innovations such as automated breeding systems, health monitoring devices, and advanced veterinary care are transforming NHP management. These technologies improve breeding efficiency, health tracking, and disease prevention, reducing costs and increasing research reliability. The integration of AI and data analytics enables predictive health management, leading to better outcomes. This trend enhances operational efficiency and supports large-scale research projects. As technology becomes more embedded in NHP care, the market is poised for growth driven by improved animal management and research productivity.
Rising Demand for NHPs in Neuroscience and Infectious Disease Research: The increasing prevalence of neurological disorders and infectious diseases has heightened the need for NHP models that closely mimic human conditions. NHPs are invaluable in studying complex brain functions and immune responses. This demand is fueling investments in specialized NHP colonies and research facilities. The impact includes accelerated drug development and better understanding of disease mechanisms. As research priorities shift towards these areas, the market is expanding to meet the growing scientific and pharmaceutical needs, fostering innovation in model development and research methodologies.
Regulatory Changes and International Collaborations: Evolving regulations aimed at ensuring ethical sourcing, animal welfare, and research transparency are shaping the market landscape. International collaborations are also facilitating access to diverse NHP species and research expertise. These changes promote standardization and compliance, but may also increase operational costs. They encourage the adoption of best practices and foster global research initiatives. The market benefits from increased credibility and expanded research opportunities, although navigating regulatory complexities remains a challenge. Overall, these developments are driving a more regulated, collaborative, and ethically conscious market environment.
In summary, these emerging trends are collectively reshaping the laboratory nonhuman primate market by fostering technological innovation, emphasizing ethical standards, and expanding research applications. They are driving growth, improving research quality, and promoting responsible practices, ultimately leading to a more advanced and sustainable industry.
Recent Developments in the Laboratory Nonhuman Primate Market
The laboratory nonhuman primate market has experienced significant growth driven by advancements in biomedical research, increasing demand for animal models, and evolving regulatory standards. As scientific research becomes more sophisticated, the need for reliable and ethically sourced nonhuman primates has surged. Technological innovations, regulatory changes, and ethical considerations are shaping the market landscape. These developments are influencing supply chains, research methodologies, and market dynamics, ultimately impacting global healthcare and pharmaceutical sectors. Understanding these key trends is essential for stakeholders aiming to navigate this evolving market effectively.
Rising demand for biomedical research: The increasing prevalence of diseases like Alzheimers and HIV/AIDS has driven the need for nonhuman primates as research models, boosting market growth and expanding research capabilities.
Technological advancements in primate breeding: Innovations such as genetic engineering and improved breeding techniques have enhanced the quality and availability of primates, reducing costs and increasing supply reliability.
Regulatory and ethical considerations: Stricter regulations and ethical debates surrounding primate research have led to more stringent sourcing and welfare standards, impacting supply chains and increasing operational costs.
Expansion of research applications: Nonhuman primates are now used in diverse fields such as neuroscience, infectious diseases, and vaccine development, broadening market scope and increasing demand across sectors.
Impact of COVID-19 pandemic: The pandemic accelerated research activities involving primates for vaccine and therapeutic development, temporarily boosting market demand but also highlighting supply chain vulnerabilities.
These developments collectively are transforming the laboratory nonhuman primate market by increasing demand, improving research quality, and prompting regulatory adaptations. The market is becoming more sophisticated, ethically conscious, and responsive to scientific needs, which will likely sustain growth and innovation in the coming years.
Strategic Growth Opportunities in the Laboratory Nonhuman Primate Market
The laboratory nonhuman primate market is experiencing rapid growth driven by advancements in biomedical research, drug development, and disease modeling. As scientific innovation accelerates, key applications are expanding, creating new opportunities for market players. These developments are fueled by increasing demand for reliable animal models to study complex human diseases, leading to enhanced research outcomes and pharmaceutical breakthroughs. The markets evolution is also influenced by regulatory changes and ethical considerations, prompting innovations in animal welfare and alternative methods. Understanding these growth opportunities across various applications is essential for stakeholders aiming to capitalize on emerging trends and drive sustainable expansion in this dynamic sector.
Drug Development: The demand for nonhuman primates in drug testing is rising due to their genetic similarity to humans, which improves the predictability of drug efficacy and safety. This application significantly impacts the market by accelerating the development of new therapeutics, especially for complex diseases like Alzheimers and HIV/AIDS. The growth in this segment is driven by increased investment in pharmaceutical R&D and stringent regulatory requirements for safety testing, making nonhuman primates indispensable in preclinical trials.
Infectious Disease Research: Nonhuman primates are crucial for studying infectious diseases such as Ebola, Zika, and COVID-19. Their use enhances understanding of disease mechanisms and vaccine development, thereby impacting the market by expanding research capabilities. The ongoing threat of emerging infectious diseases and the need for effective vaccines are fueling demand, positioning primates as vital models for rapid response and containment strategies.
Neuroscience and Cognitive Research: The application of nonhuman primates in neuroscience is expanding due to their complex brain structures, which closely resemble humans. This growth opportunity impacts the market by enabling breakthroughs in understanding neurological disorders like Parkinsons and autism. Increased funding and technological advancements in imaging and behavioral analysis are further propelling this segment, leading to more targeted therapies and improved patient outcomes.
Toxicology Testing: Nonhuman primates are used extensively in toxicology studies to assess the safety of new drugs and chemicals. This application influences market growth by providing critical safety data that regulatory agencies require for approval processes. The focus on ethical testing alternatives is prompting innovations, but the demand for accurate primate models remains high, especially for compounds with potential human health impacts.
Regenerative Medicine and Stem Cell Research: The use of nonhuman primates in regenerative medicine is gaining traction for studying stem cell therapies and tissue engineering. This application impacts the market by facilitating the development of advanced treatments for degenerative diseases and injuries. The close physiological similarities to humans make primates ideal models, attracting investments and fostering innovation in personalized medicine.
In summary, these key growth opportunities are significantly shaping the laboratory nonhuman primate market by expanding research capabilities, accelerating drug development, and fostering innovation across multiple biomedical fields. The increasing reliance on primate models underscores their critical role in advancing human health, despite ethical considerations, and highlights the markets potential for sustained growth and technological evolution.
Laboratory Nonhuman Primate Market Driver and Challenges
The laboratory nonhuman primate market is influenced by a complex interplay of technological advancements, economic factors, and regulatory frameworks. Innovations in biomedical research and drug development drive demand for nonhuman primates, while economic considerations such as funding and cost-efficiency impact market growth. Additionally, regulatory policies governing animal welfare and research ethics significantly shape operational practices and market expansion. These factors collectively create opportunities and challenges that determine the trajectory of this specialized market. Understanding these drivers and challenges is essential for stakeholders aiming to navigate the evolving landscape effectively and ensure sustainable growth within ethical and legal boundaries.
The factors responsible for driving the laboratory nonhuman primate market include:-
Technological Advancements: The development of sophisticated research tools and genetic engineering techniques has enhanced the utility of nonhuman primates in biomedical research. These innovations enable more accurate disease modeling and drug testing, increasing demand for primates. As research becomes more precise and efficient, pharmaceutical companies and research institutions are investing heavily in primate models, which accelerates market growth. Moreover, advancements in imaging and behavioral analysis improve data collection, making primates indispensable for complex studies. This technological progress ensures the market remains dynamic and aligned with cutting-edge scientific needs.
Rising Investment in Biomedical Research: Governments, private organizations, and pharmaceutical companies are increasing funding for biomedical research, particularly in areas like infectious diseases, neuroscience, and genetic disorders. Nonhuman primates are crucial for translational research due to their genetic similarity to humans, making them highly valuable for developing new therapies. The surge in research activities directly correlates with higher demand for primates, fueling market expansion. Additionally, the global focus on emerging health threats, such as pandemics, has led to increased funding for primate-based studies, further propelling market growth and innovation.
Regulatory and Ethical Frameworks: Stringent regulations and ethical considerations influence the supply, use, and welfare standards of nonhuman primates in research. Governments and international bodies enforce strict guidelines to ensure humane treatment and minimize animal suffering, which can limit supply and increase operational costs. Compliance with these regulations requires significant investment in facilities, training, and ethical review processes, impacting market dynamics. While these frameworks aim to promote ethical research, they also pose challenges by potentially restricting the availability of primates and increasing the complexity of research approval processes, thereby affecting market growth.
Growing Demand for Personalized Medicine: The shift towards personalized medicine and targeted therapies has increased the need for accurate disease models, which nonhuman primates provide due to their physiological similarities to humans. This demand drives research institutions and pharmaceutical companies to invest in primate studies to develop tailored treatments. As personalized medicine becomes more prevalent, the market for primates expands, supporting the development of innovative therapies. This trend underscores the importance of primates in bridging the gap between laboratory research and clinical application, fostering market growth through specialized research needs.
Expansion of Contract Research Organizations (CROs): The rise of CROs specializing in preclinical testing has contributed significantly to the market. These organizations offer dedicated services for primate research, providing expertise, facilities, and compliance management. Their growth enables pharmaceutical and biotech companies to outsource complex primate studies, reducing costs and accelerating drug development timelines. The increasing reliance on CROs enhances market accessibility and scalability, making primate research more efficient and widespread. This expansion supports the overall growth of the laboratory nonhuman primate market by facilitating high-quality, compliant research services.
The challenges facing this laboratory nonhuman primate market include:-
Ethical Concerns and Public Opposition: Ethical debates surrounding the use of nonhuman primates in research pose significant challenges. Public opposition and animal rights activism pressure regulatory bodies and research institutions to reduce or eliminate primate testing. These concerns can lead to stricter regulations, funding restrictions, and increased scrutiny, which may limit research opportunities. Balancing scientific progress with ethical considerations remains a complex issue, often resulting in delays, increased costs, and potential bans on certain types of research involving primates. This societal scrutiny influences market dynamics and necessitates ongoing dialogue and reform.
Regulatory Restrictions and Compliance Costs: The market faces challenges from evolving regulatory landscapes that impose rigorous standards for animal welfare, research protocols, and facility management. Compliance requires substantial investments in infrastructure, staff training, and documentation, increasing operational costs. Regulatory delays and approvals can slow down research projects, impacting market growth and innovation. Navigating these complex legal frameworks demands significant resources, which may be prohibitive for smaller organizations, thereby limiting market accessibility and expansion.
Supply Chain and Ethical Sourcing Issues: Securing a consistent and ethically sourced supply of nonhuman primates remains a challenge. Ethical sourcing involves ensuring that primates are obtained through humane breeding or acquisition practices, which can be limited by regulatory constraints and ethical debates. Disruptions in supply chains due to legal restrictions or public opposition can hinder research activities. Additionally, concerns over the sustainability and welfare of primates in captivity influence sourcing practices, adding complexity and cost to procurement processes. These issues threaten the stability and growth of the market by constraining availability and increasing operational risks.
In summary, the laboratory nonhuman primate market is shaped by rapid technological innovations, increased research funding, and evolving regulatory standards, all of which drive growth. However, ethical concerns, regulatory hurdles, and sourcing challenges pose significant obstacles. The interplay of these factors creates a dynamic environment where market expansion depends on balancing scientific advancement with ethical responsibility. Stakeholders must navigate these drivers and challenges carefully to foster sustainable growth, ensuring that research progresses ethically and efficiently while adhering to legal frameworks. Overall, the markets future hinges on innovation, ethical practices, and regulatory adaptability.
List of Laboratory Nonhuman Primate Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies laboratory nonhuman primate companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the laboratory nonhuman primate companies profiled in this report include-
Vanny Bio Research
HZ-Bio
Envigo
JOINN LABORATORIES
WuXi AppTec
Jingang Biotech
Charles River
Pharmaron
Xishan Zhongke
ONPRC
Laboratory Nonhuman Primate Market by Segment
The study includes a forecast for the global laboratory nonhuman primate market by type, application, and region.
Laboratory Nonhuman Primate Market by Type [Value from 2019 to 2031]:
Macaca Fascicularis
Rhesus Monkey
Others
Laboratory Nonhuman Primate Market by Application [Value from 2019 to 2031]:
Contract Research & Development Service Organization Company
Scientific Research Institution
Colleges & Universities
Others
Laboratory Nonhuman Primate Market by Region [Value from 2019 to 2031]:
North America
Europe
Asia Pacific
The Rest of the World
Country Wise Outlook for the Laboratory Nonhuman Primate Market
The laboratory nonhuman primate market has experienced significant shifts driven by technological advancements, regulatory changes, and increasing demand for biomedical research globally. Countries are investing heavily in research infrastructure and ethical standards, influencing market dynamics. The United States remains a leader in research and development, while China is rapidly expanding its capabilities. Germany emphasizes ethical practices and innovation, India is increasing its research output, and Japan continues to focus on technological integration. These developments reflect a global trend toward more sophisticated, ethical, and efficient use of nonhuman primates in scientific studies, shaping the future landscape of this specialized market.
United States: The US market is characterized by advanced research infrastructure, strict regulatory standards, and high investment in biomedical research. Leading institutions are adopting innovative technologies like genetic editing and imaging, which enhance research capabilities. The government and private sector are collaborating to improve ethical standards and animal welfare, driving market growth. The demand for nonhuman primates in neuroscience, infectious diseases, and vaccine development remains high, supporting ongoing market expansion.
China: China is experiencing rapid growth in the laboratory nonhuman primate market, fueled by increased government funding and a focus on biomedical research. The country is expanding its research facilities and adopting advanced breeding and genetic modification techniques. Regulatory frameworks are evolving to support ethical research practices, although challenges remain. China's emphasis on infectious disease research and vaccine development has significantly contributed to market growth, positioning it as a key global player.
Germany: Germany emphasizes ethical standards and scientific innovation in the laboratory nonhuman primate market. The country invests in state-of-the-art research facilities and promotes strict animal welfare regulations. German research institutions are pioneering in areas such as neuroscience and pharmacology, utilizing advanced imaging and behavioral analysis. The market is driven by collaborations within the European Union and a focus on sustainable and ethical research practices, ensuring high-quality data and compliance.
India: India is witnessing a surge in research activities involving nonhuman primates, supported by government initiatives and increasing private sector investment. The country is expanding its breeding facilities and adopting modern research methodologies. Regulatory frameworks are being strengthened to ensure ethical standards, although there is room for improvement. India's focus on infectious diseases, vaccine research, and emerging biomedical fields is fueling market growth, making it an important emerging hub in this sector.
Japan: Japan continues to prioritize technological innovation and ethical research practices in the laboratory nonhuman primate market. The country invests heavily in advanced imaging, genetic research, and behavioral studies. Japanese institutions are leading in neuroscience and pharmacology, with a strong emphasis on animal welfare and regulatory compliance. The market benefits from collaborations with global research organizations and a focus on developing sustainable, ethical research models, maintaining Japan's position as a key player in this field.
Features of the Global Laboratory Nonhuman Primate Market
Market Size Estimates: Laboratory nonhuman primate market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Laboratory nonhuman primate market size by type, application, and region in terms of value ($B).
Regional Analysis: Laboratory nonhuman primate market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the laboratory nonhuman primate market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the laboratory nonhuman primate market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the laboratory nonhuman primate market by type (macaca fascicularis, rhesus monkey, and others), application (contract research & development service organization company, scientific research institution, colleges & universities, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain
3. Market Trends & Forecast Analysis
3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
4. Global Laboratory Nonhuman Primate Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Macaca Fascicularis : Trends and Forecast (2019-2031)
4.4 Rhesus Monkey : Trends and Forecast (2019-2031)
4.5 Others : Trends and Forecast (2019-2031)
5. Global Laboratory Nonhuman Primate Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Contract Research & Development Service Organization Company : Trends and Forecast (2019-2031)
5.4 Scientific Research Institution : Trends and Forecast (2019-2031)
5.5 Colleges & Universities : Trends and Forecast (2019-2031)
5.6 Others : Trends and Forecast (2019-2031)
6. Regional Analysis
6.1 Overview
6.2 Global Laboratory Nonhuman Primate Market by Region
7. North American Laboratory Nonhuman Primate Market
7.1 Overview
7.2 North American Laboratory Nonhuman Primate Market by Type
7.3 North American Laboratory Nonhuman Primate Market by Application
7.4 The United States Laboratory Nonhuman Primate Market
7.5 Canadian Laboratory Nonhuman Primate Market
7.6 Mexican Laboratory Nonhuman Primate Market
8. European Laboratory Nonhuman Primate Market
8.1 Overview
8.2 European Laboratory Nonhuman Primate Market by Type
8.3 European Laboratory Nonhuman Primate Market by Application
8.4 German Laboratory Nonhuman Primate Market
8.5 French Laboratory Nonhuman Primate Market
8.6 Italian Laboratory Nonhuman Primate Market
8.7 Spanish Laboratory Nonhuman Primate Market
8.8 The United Kingdom Laboratory Nonhuman Primate Market
9. APAC Laboratory Nonhuman Primate Market
9.1 Overview
9.2 APAC Laboratory Nonhuman Primate Market by Type
9.3 APAC Laboratory Nonhuman Primate Market by Application
9.4 Chinese Laboratory Nonhuman Primate Market
9.5 Indian Laboratory Nonhuman Primate Market
9.6 Japanese Laboratory Nonhuman Primate Market
9.7 South Korean Laboratory Nonhuman Primate Market
9.8 Indonesian Laboratory Nonhuman Primate Market
10. ROW Laboratory Nonhuman Primate Market
10.1 Overview
10.2 ROW Laboratory Nonhuman Primate Market by Type
10.3 ROW Laboratory Nonhuman Primate Market by Application
